Cargando…

Glycyrrhizic acid derivatives as Dengue virus inhibitors

Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Baltina, Lidia A., Tasi, Yan-Ting, Huang, Su-Hua, Lai, Hsueh-Chou, Baltina, Lia A., Petrova, Svetlana F., Yunusov, Marat S., Lin, Cheng-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172207/
https://www.ncbi.nlm.nih.gov/pubmed/31519375
http://dx.doi.org/10.1016/j.bmcl.2019.126645
_version_ 1783524211607732224
author Baltina, Lidia A.
Tasi, Yan-Ting
Huang, Su-Hua
Lai, Hsueh-Chou
Baltina, Lia A.
Petrova, Svetlana F.
Yunusov, Marat S.
Lin, Cheng-Wen
author_facet Baltina, Lidia A.
Tasi, Yan-Ting
Huang, Su-Hua
Lai, Hsueh-Chou
Baltina, Lia A.
Petrova, Svetlana F.
Yunusov, Marat S.
Lin, Cheng-Wen
author_sort Baltina, Lidia A.
collection PubMed
description Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.
format Online
Article
Text
id pubmed-7172207
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71722072020-04-22 Glycyrrhizic acid derivatives as Dengue virus inhibitors Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen Bioorg Med Chem Lett Article Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection. Elsevier Ltd. 2019-10-15 2019-08-29 /pmc/articles/PMC7172207/ /pubmed/31519375 http://dx.doi.org/10.1016/j.bmcl.2019.126645 Text en © 2019 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Baltina, Lidia A.
Tasi, Yan-Ting
Huang, Su-Hua
Lai, Hsueh-Chou
Baltina, Lia A.
Petrova, Svetlana F.
Yunusov, Marat S.
Lin, Cheng-Wen
Glycyrrhizic acid derivatives as Dengue virus inhibitors
title Glycyrrhizic acid derivatives as Dengue virus inhibitors
title_full Glycyrrhizic acid derivatives as Dengue virus inhibitors
title_fullStr Glycyrrhizic acid derivatives as Dengue virus inhibitors
title_full_unstemmed Glycyrrhizic acid derivatives as Dengue virus inhibitors
title_short Glycyrrhizic acid derivatives as Dengue virus inhibitors
title_sort glycyrrhizic acid derivatives as dengue virus inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172207/
https://www.ncbi.nlm.nih.gov/pubmed/31519375
http://dx.doi.org/10.1016/j.bmcl.2019.126645
work_keys_str_mv AT baltinalidiaa glycyrrhizicacidderivativesasdenguevirusinhibitors
AT tasiyanting glycyrrhizicacidderivativesasdenguevirusinhibitors
AT huangsuhua glycyrrhizicacidderivativesasdenguevirusinhibitors
AT laihsuehchou glycyrrhizicacidderivativesasdenguevirusinhibitors
AT baltinaliaa glycyrrhizicacidderivativesasdenguevirusinhibitors
AT petrovasvetlanaf glycyrrhizicacidderivativesasdenguevirusinhibitors
AT yunusovmarats glycyrrhizicacidderivativesasdenguevirusinhibitors
AT linchengwen glycyrrhizicacidderivativesasdenguevirusinhibitors